title: A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
abstract: Scientific community is striving to understand the role of heterocycles and fused heterocycles in drug discovery programme due to its impact on multi-drug resistance (MDR) of anticancer drugs. Architecting of various scaffolds for cancer treatment has become gradually increased in many years. Till now there is no treatment which is so proficient that it can cure the cancer from the roots. Hence, it is very necessary to design novel anticancer agents with minimum side effects. Synthesis of hybrids from natural leads is one of the rationale approaches in medicinal chemistry. It remains a big challenge to invent new efficient drugs to beat cancer. The design and synthesis of fused molecules as anticancer agents is one of the great innovations of modern era. In drug discovery archetype, a variety of heterocycles have been considered for the development of novel lead compounds. This article presents some recent advancements in the field of anticancer heterocyclic agents all around the world and also attracted the structure activity relationship along with the structure of the most promising molecules along with IC50 values against various human cancer cell lines.
authors: Dinesh
authors: D
authors: Kumar
authors: Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab- 143005, India.
authors: Subheet Kumar
authors: SK
authors: Jain
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001393:Azoles / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity; D001688:Biological Products / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006571:Heterocyclic Compounds / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity; D009369:Neoplasms / Q000188:drug therapy; D011725:Pyridines / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity; D011799:Quinazolines / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity
chemical_list: D000970:Antineoplastic Agents; D001393:Azoles; D001688:Biological Products; D006571:Heterocyclic Compounds; D007211:Indoles; D011725:Pyridines; D011799:Quinazolines